Evaluation of the effectiveness of the Saving Babies Lives Care Bundle Version 2 on reducing perinatal mortality (eVOLVE): a mixed-methods approach.
In April 2022, NHS England commissioned the University of Manchester to conduct an independent evaluation of the effectiveness of the Saving Babies’ Lives Care Bundle Version 2 (SBLCBv2) on reducing perinatal mortality in England. The study was commissioned in two phases.
Phase 1 comprised a national evaluation of the impact of the SBLCBv2 on perinatal mortality rates, associated clinical outcomes, and any unintended consequences using routine data derived from national databases. Phase 2 comprised a mixed-methods evaluation to further understand the impact on maternity services, women and their families.This protocol covers Phase 2 of the evaluation only.
Phase 2 was conducted in 28 maternity units across England using a mixed-methods approach. The views and experiences of women and healthcare professionals towards maternity care in relation to the SBLCBv2 were sought using surveys and interviews.